APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 73 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,019,009 | -30.9% | 78,702 | +5.8% | 0.00% | -33.3% |
| Q1 2024 | $4,371,469 | -19.0% | 74,370 | -17.5% | 0.01% | -14.3% |
| Q4 2023 | $5,398,833 | +50.6% | 90,191 | -4.3% | 0.01% | +16.7% |
| Q3 2023 | $3,585,993 | -62.3% | 94,269 | -9.8% | 0.01% | -53.8% |
| Q2 2023 | $9,518,766 | +28.2% | 104,487 | -7.2% | 0.01% | +18.2% |
| Q1 2023 | $7,427,294 | +26.1% | 112,603 | -1.1% | 0.01% | +22.2% |
| Q4 2022 | $5,890,234 | -21.9% | 113,909 | +3.2% | 0.01% | -30.8% |
| Q3 2022 | $7,538,000 | +57.8% | 110,360 | +4.5% | 0.01% | +62.5% |
| Q2 2022 | $4,776,000 | -5.0% | 105,614 | +6.8% | 0.01% | +14.3% |
| Q1 2022 | $5,027,000 | +2.5% | 98,930 | -4.6% | 0.01% | +16.7% |
| Q4 2021 | $4,903,000 | +75.8% | 103,701 | +22.6% | 0.01% | +50.0% |
| Q3 2021 | $2,789,000 | -50.7% | 84,617 | -5.5% | 0.00% | -42.9% |
| Q2 2021 | $5,658,000 | +45.6% | 89,522 | -1.1% | 0.01% | +40.0% |
| Q1 2021 | $3,886,000 | -25.2% | 90,557 | -0.3% | 0.01% | -28.6% |
| Q4 2020 | $5,195,000 | +89.4% | 90,830 | -0.1% | 0.01% | +75.0% |
| Q3 2020 | $2,743,000 | -7.2% | 90,923 | +0.4% | 0.00% | -20.0% |
| Q2 2020 | $2,957,000 | +26.9% | 90,546 | +4.1% | 0.01% | 0.0% |
| Q1 2020 | $2,330,000 | +2.0% | 86,974 | +16.6% | 0.01% | +25.0% |
| Q4 2019 | $2,284,000 | +25.8% | 74,591 | -1.0% | 0.00% | 0.0% |
| Q3 2019 | $1,815,000 | -3.8% | 75,326 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $1,886,000 | +75.0% | 74,417 | +34.6% | 0.00% | +100.0% |
| Q1 2019 | $1,078,000 | +44.3% | 55,297 | -2.4% | 0.00% | 0.0% |
| Q4 2018 | $747,000 | -24.0% | 56,645 | +2.5% | 0.00% | 0.0% |
| Q3 2018 | $983,000 | -19.2% | 55,268 | -0.0% | 0.00% | -33.3% |
| Q2 2018 | $1,216,000 | +228.6% | 55,271 | +230.4% | 0.00% | +200.0% |
| Q1 2018 | $370,000 | 0.0% | 16,727 | -2.0% | 0.00% | 0.0% |
| Q4 2017 | $370,000 | – | 17,066 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 624,962 | $20,599,000 | 13.29% |
| Octagon Capital Advisors LP | 1,595,911 | $52,601,000 | 12.95% |
| Logos Global Management LP | 1,450,000 | $47,792,000 | 3.45% |
| Avoro Capital Advisors LLC | 5,000,000 | $164,800,000 | 2.59% |
| Ghost Tree Capital, LLC | 200,000 | $6,592,000 | 1.93% |
| Integral Health Asset Management, LLC | 190,000 | $6,262,000 | 1.80% |
| GREAT POINT PARTNERS LLC | 200,000 | $6,592,000 | 1.54% |
| Aufman Associates Inc | 53,642 | $1,768,000 | 1.45% |
| Ghost Tree Capital, LLC | 150,000 | $4,944,000 | 1.45% |
| Altium Capital Management LP | 166,700 | $5,494,000 | 1.44% |